Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Quantum Q1 EPS $(0.04), Inline, Sales $97.07M Beat $94.07M Estimate

Quantum (NASDAQ:QMCO) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. The company reported quarterly sales of $97.07 million which beat the analyst consensus estimate of $94.07
byBenzinga Newsdesk
August 4, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Quantum (NASDAQ:QMCO) reported quarterly losses of $(0.04) per share which met the analyst consensus estimate. The company reported quarterly sales of $97.07 million which beat the analyst consensus estimate of $94.07 million by 3.19 percent. This is a 8.95 percent increase over sales of $89.10 million the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Biomea Fusion Presents Achievement Of Minimal Residual Disease Negativity In First Complete Responder From Ongoing Phase I Study Of BMF-219 In Patients With Relapsed Or Refractory Acute Myeloid Leukemia At The 2023 ASH Annual Meeting

By Benzinga Newsdesk
December 11, 10:27 AM
BMF-219 demonstrated early signs of clinical activity and ability to achieve durable and sustained complete responses (CRs) with minimal residual disease negativity (MRD-neg) in acute myeloid leukemia (AML)

BMEA